In this cohort, the presence of TP53 aberrations, a relapsed/refractory CLL status, and high LDH or β2-M levels were significantly associated with prognosis both in univariate and multivariate analysis. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.